The Global Balloon Catheter Market is anticipated to be valued at around US$ 6.99 billion by 2030, according to the report. A balloon catheter is a clinical tool for diverse healing and diagnostic processes. Comprising an inflatable balloon at its tip, it finds widespread use in angioplasty to widen narrowed blood vessels, specifically in treating coronary artery disorder. The catheter is threaded through vessels to the site of the blockage, wherein the balloon is inflated, compressing the plaque and restoring blood glide. Also, balloon catheters are hired for procedures including stent placement and valvuloplasty. Their versatility, minimally invasive nature, and efficacy make balloon catheters critical gear in interventional cardiology and other scientific fields, revolutionizing vascular interventions worldwide.
Moreover, continuous materials, design, and functionality improvements enhance balloon catheters' effectiveness and flexibility, while progressed imaging techniques contribute to extra precision and improved treatment alternatives. Beyond their traditional role in angioplasty for opening blocked arteries, balloon catheters are diversifying their packages throughout specialties, urology, oncology, and neurology. This evolution into multiple scientific domains propels the market's boom, reflecting the gadgets' adaptability and broadening their effect in numerous healthcare settings.
Likewise, rising healthcare spending in emerging economies propels the escalating demand for advanced clinical technologies, including balloon catheters. Foreseeing development in customized remedies, tailored catheters are predicted to heighten efficacy and safety. The integration of telemedicine in balloon catheter processes promises enhanced accessibility and cost-effectiveness, specifically in remote regions. Artificial Intelligence (AI) technology is set to help in prognosis, treatment planning, and image evaluation, bolstering the precision and effectiveness of balloon catheter tactics.
While North America and Europe currently dominate, the Asia Pacific vicinity reports the swiftest increase due to its significant population and growing healthcare spending. Pioneering players like Cardiant Inc. and the Terumo-MicroPort Scientific joint venture exemplify revolutionary tactics, enriching the dynamic balloon catheter market panorama. Hence, the Global Balloon Catheter Market was valued at US$ 4.43 Billion in 2023.
In April 2022-The study on Terumo Corporation's most recent bobby balloon guide catheter has seen the first patient enrolment.
In July 2021-The latest drug-coated balloon catheter from Medtronic, called PrevailTM, was introduced in Europe to treat coronary artery disease following the CE (ConformitéEuropéene) mark for the product.
This research report provides a detailed and comprehensive insight of the Global Balloon Catheter Industry.
Global Balloon Catheter Market is expected to expand at a CAGR of 6.73% from 2024-2030
As the worldwide population ages, the demand for medical interventions rises, and balloon catheters become essential for addressing age-associated cardiovascular and other conditions. These devices, offering an inflatable balloon at the tip, are pivotal in angioplasty, widening narrowed blood vessels, especially in treating well-known situations like coronary artery disease among the aged. The growing prevalence of age-associated cardiovascular problems propels balloon catheter demand, significantly increasing the medical device market and enhancing the care of growing older populations globally. Offering minimally invasive alternatives to conventional surgeries, balloon catheters lead to faster recuperation instances, decreased dangers, and progressed patient effects, driving market increase towards minimally invasive tactics.Moreover, continuous materials, design, and functionality improvements enhance balloon catheters' effectiveness and flexibility, while progressed imaging techniques contribute to extra precision and improved treatment alternatives. Beyond their traditional role in angioplasty for opening blocked arteries, balloon catheters are diversifying their packages throughout specialties, urology, oncology, and neurology. This evolution into multiple scientific domains propels the market's boom, reflecting the gadgets' adaptability and broadening their effect in numerous healthcare settings.
Likewise, rising healthcare spending in emerging economies propels the escalating demand for advanced clinical technologies, including balloon catheters. Foreseeing development in customized remedies, tailored catheters are predicted to heighten efficacy and safety. The integration of telemedicine in balloon catheter processes promises enhanced accessibility and cost-effectiveness, specifically in remote regions. Artificial Intelligence (AI) technology is set to help in prognosis, treatment planning, and image evaluation, bolstering the precision and effectiveness of balloon catheter tactics.
While North America and Europe currently dominate, the Asia Pacific vicinity reports the swiftest increase due to its significant population and growing healthcare spending. Pioneering players like Cardiant Inc. and the Terumo-MicroPort Scientific joint venture exemplify revolutionary tactics, enriching the dynamic balloon catheter market panorama. Hence, the Global Balloon Catheter Market was valued at US$ 4.43 Billion in 2023.
Drug Eluting Balloon Catheters (DEBCs) have the potential to dominate the market and revolutionize vascular interventions for a broader range of patients worldwide
By product type, the Global Balloon Catheter Market is divided into Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, Scoring Balloon Catheter, Stent Graft Balloon Catheter, and Others. Drug Eluting Balloon Catheters (DEBCs) release anti-proliferative drugs post-angioplasty, minimizing restenosis hazards compared to plain balloon catheters. This results in advanced long-term period results, reducing repeat processes and healthcare charges. DEBCs showcase versatility, applicable to a broader range of vessel sizes and places than traditional bare-metal stents, expanding treatment alternatives. Their minimally invasive nature, corresponding to ordinary balloon catheters, guarantees faster restoration, fewer headaches, and a progressed patient experience, fuelling the trend towards minimally invasive techniques. This multifaceted gain positions DEBCs as a significant development in interventional cardiology.Coronary artery disease (CAD), the leading cause of cardiovascular death worldwide, is undeniably fuelling a significant surge in the global balloon catheter market
By indication, the Global Balloon Catheter Market is fragmented into Coronary Artery Disease and Peripheral Vascular Disease. Globally, an anticipated 17.9 million individuals contend with Coronary Artery Disease (CAD), a figure projected to grow due to aging populations, dangerous lifestyles, and urbanization. CAD poses the dangers of narrowed coronary heart arteries, leading to heart attacks, strokes, and coronary heart failure. In the treatment panorama, balloon catheters are pivotal in minimally invasive approaches like angioplasty and stenting, mitigating signs and symptoms by restoring blood flow. Their benefits, which include quicker restoration, reduced dangers, and shorter hospital stays than standard bypass surgery, make them relatively preferred choices. Various catheter kids cope with particular needs, and continuous technological improvements drive precision, efficacy, and market boom.Nylon continues to hold its ground as the leading raw material in the global balloon catheter market
The Global Balloon Catheter Market is categorized into Polyurethane, Nylon, and Others by raw materials. Nylon, prized for its muscular tensile strength, is essential for catheters navigating sensitive blood vessels for the duration of balloon inflation. Its biocompatibility reduces immunological responses, minimizing irritation or rejection risks. Nylon's flexibility permits particular catheter maneuvering, facilitating focused treatment with minimum damage. Cost-effective in comparison to alternatives like polyurethane, nylon is easily reachable for producers and healthcare companies. Ongoing innovations, including enhanced biocompatibility coatings, ensure its edge in performance. Versatile in various catheter kinds, nylon adapts to applications from angioplasty to drug-eluting balloons, extending into rising medical fields like urology, neurology, and oncology.Rise of clinics in the global balloon catheter market reflects a growing demand for accessible, affordable, and convenient healthcare solutions
By end-user, the Global Balloon Catheter Market comprises Hospitals, Clinics, Ambulatory Surgical Centers, and Diagnostic Centers. Compared to hospitals, clinics offer inexpensive methods with lower overheads and administrative burdens, probably attracting uninsured or underinsured people. Clinics offer convenience with shorter wait times and flexible scheduling, improving accessibility for brief diagnosis and treatment. Technological improvements in balloon catheter technology and imaging structures have streamlined strategies, making them shorter, less complicated, and more precise for safe outpatient settings. The surrounding health facility aligns with the trend of minimally invasive techniques, promoting quicker recuperation instances and reduced hospitalization needs, emphasizing the developing significance of clinics in current healthcare.United States holds a substantial share of the global balloon catheter market
By country, the Global Balloon Catheter Market is divided into the United States, Canada, France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Turkey, China, Japan, India, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand, Brazil, Mexico, Argentina, Saudi Arabia, United Arab Emirates, South Africa, and Rest of the World. The U.S., housing premier biomedical research establishments and leading medical device agencies, is a hotbed of balloon catheter innovation in materials, design, and capability. Strong intellectual property protection incentivizes research and development, yielding patented technology with a competitive aspect. A sturdy scientific research infrastructure ensures rigorous testing before market access. The U.S. gives market advantages with its massive and affluent population, advanced healthcare system, and well-established supply chain. Regulatory favourability is evident through a streamlined FDA approval process, high requirements, and a predictable regulatory environment, supplying stability and confidence for companies investing in the balloon catheter market.Key Players
Abbott Laboratories, Becton Dickinson and Company, Cardinal Health, Teleflex Incorporated, Medtronic Plc., Johnson and Johnson, Edwards Lifesciences Corporation, Stryker Corporation, and Smith & Nephew are in the global balloon catheter market.In April 2022-The study on Terumo Corporation's most recent bobby balloon guide catheter has seen the first patient enrolment.
In July 2021-The latest drug-coated balloon catheter from Medtronic, called PrevailTM, was introduced in Europe to treat coronary artery disease following the CE (ConformitéEuropéene) mark for the product.
This research report provides a detailed and comprehensive insight of the Global Balloon Catheter Industry.
Product Type - Global Balloon Catheter Market breakup from 6 viewpoints:
- Normal Balloon Catheter
- Drug Eluting Balloon Catheter
- Cutting Balloon Catheter
- Scoring Balloon Catheter
- Stent Graft Balloon Catheter
- Others
Indication - Global Balloon CatheterMarket breakup from 2 viewpoints:
- Coronary Artery Disease
- Peripheral Vascular Disease
Raw Materials - Global Balloon Catheter Market breakup from 3 viewpoints:
- Polyurethane
- Nylon
- Others
End-User - Global Balloon CatheterMarket breakup from 4 viewpoints:
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
Country - Market breakup from 26 Country Global Balloon Catheter Industry viewpoints:
North America
- United States
- Canada
Europe
- France
- Germany
- Italy
- Spain
- United Kingdom
- Belgium
- Netherland
- Turkey
Asia Pacific
- China
- Japan
- India
- South Korea
- Thailand
- Malaysia
- Indonesia
- Australia
- New Zealand
Latin America
- Brazil
- Mexico
- Argentina
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
Rest of the World
All companies have been covered from 3 viewpoints:
- Overview
- Recent Developments
- Revenue
Company Analysis
- Abbott Laboratories
- Becton Dickinson and Company
- Cardinal Health
- Teleflex Incorporated
- Medtronic Plc.
- Johnson and Johnson
- Edwards Lifesciences Corporation
- Stryker Corporation
- Smith & Nephew
Table of Contents
1. Introduction2. Research Methodology3. Executive Summary5. Global Balloon Catheter Market
4. Market Dynamics
6. Market Share - Global Balloon Catheter Market
7. Product Type - Global Balloon Catheter Market
8. Indication - Global Balloon Catheter Market
9. Raw Material - Global Balloon Catheter Market
10. End Users - Global Balloon Catheter Market
11. Countries - Global Balloon Catheter Market
12. Porter’s Five Forces Analysis - Global Balloon Catheter Market
13. SWOT Analysis - Global Balloon CatheterMarket
14. Key Players Analysis
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- Becton Dickinson and Company
- Cardinal Health
- Teleflex Incorporated
- Medtronic plc
- Johnson and Johnson
- Edwards Lifesciences Corporation
- Stryker Corporation
- Smith & Nephew
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 230 |
| Published | January 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 4.43 Billion |
| Forecasted Market Value ( USD | $ 6.99 Billion |
| Compound Annual Growth Rate | 6.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 9 |
